Skip to content

Intrathecal Dexmedetomidine vs Midazolame

Prospective Randomized Controlled Clinical Trial to Compare Intrathecal Dexmedetomidine Versus Midazolame in Orthopedic Cancer Surgeries

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06315634
Enrollment
75
Registered
2024-03-18
Start date
2021-03-15
Completion date
2022-03-10
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Prospective Randomized Controlled Clinical Trial to Compare Intrathecal Dexmedetomidine Versus Midazolame in Orthopedic Cancer Surgeries

Detailed description

Comparison of intrathecal dexmedetomidine plus Bupivacaine vs intrathecal midazolam plus Bupivacaine on duration of sensory and motor blockade and hemodynamic parameters of patients

Interventions

DRUGDexmedetomidine

5 micrograms intrathecal dexmedetomidine

DRUGMidazolam

2 milligrams intrathecal midazolam

DRUGBupivacain

12.5 milligrams 0.5% intrathecal hyperbaric bupivacaine

Sponsors

National Cancer Institute, Egypt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing lower limb orthopedic cancer surgery. * ASA I, II, III. * Age 20 to 70 year * Healthy volunteers

Exclusion criteria

* Age less than 20 and older than 70. * ASA IV, V. * patients' refusal. * patients with coagulopathy. * patients with severe valvular stenosis * patients with infection at site of injection

Design outcomes

Primary

MeasureTime frameDescription
Duration of sensory block12 hoursDuration of sensory block after spinal anesthesia by the ability of the patient to demonstrate the pinprick sensation

Secondary

MeasureTime frameDescription
Incidence of vomiting occurrence12 hoursThe patient will be reported in case of vomiting occurrence
Sedation12 hoursRamsay's sedation score1: anxious, agitated and restlessness, 2: oriented and cooperative, 3: responds to command only, 4: brisk response to loud voice and light glabellar tap, 5: sluggish to no response to light glabellar tap or loud auditory stimulus, 6: no response even to pain
Change in mean arterial blood pressure12 hoursNon invasive blood pressure measurement
Duration of motor block12 hoursAbility of patient to regain full motor power
Change in heart rate12 hoursHeart rate will be compared between the three groups and will be compared with baseline preoperative values in each group

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026